eprintid: 99120
rev_number: 3
eprint_status: archive
dir: disk0/00/09/91/20
datestamp: 2026-06-19 07:21:00
lastmod: 2026-06-19 07:21:00
status_changed: 2026-06-19 07:21:00
type: article
metadata_visibility: show
creators_name: Jumayeva M.F., Jumayeva M.F.
creators_name: Ahmedova N.Sh., Ahmedova N.Sh.
title: POSSIBILITIES OF MODERN THERAPY OF LIVER CIRRHOSIS AND TYPE 2 HEPATORENAL SYNDROME
ispublished: pub
abstract: Hepatorenal syndrome (HRS) is a severe complication that occurs in patients with cirrhosis of the liver (LC), characterized by clinical manifestations of renal failure (RF). Type 2 HRS is observed in patients with severe ascites that are refractory to diuretics. The average survival time of patients with type 2 HRS is 6 months. The laboratory criteria for type 2 HRS are the level of creatinine in the blood serum (above 150 mmol/l), characterized by a high plasma content of renin, aldosterone and antidiuretic hormone. Kidney failure develops slowly .
date: 2025-01-22
official_url: https://universalconference.us/index.php/ICNSHS/article/view/3643
full_text_status: public
publication: INTERNATIONAL CONFERENCE OF NATURAL AND SOCIAL-HUMANITARIAN SCIENCES
volume: 2
number: 1
pagerange: 9-10
citation:   Jumayeva M.F., Jumayeva M.F., Ahmedova N.Sh., Ahmedova N.Sh.  (2025) POSSIBILITIES OF MODERN THERAPY OF LIVER CIRRHOSIS AND TYPE 2 HEPATORENAL SYNDROME.  INTERNATIONAL CONFERENCE OF NATURAL AND SOCIAL-HUMANITARIAN SCIENCES, 2 (1).  pp. 9-10.      
document_url: https://arxiv.universalpublishings.com/id/eprint/99120/1/9-10_Jumayeva.pdf